The nature of PI3K inhibition itself is likely to provide a supportive environment for new mutations to occur, as PI3K inhibition in vitro is not cytotoxic but mostly cytostatic for cancer cells (58, 159, 160). This evidence concerns the gene PIK3CD and cancer.